58
Participants
Start Date
August 19, 2021
Primary Completion Date
November 1, 2025
Study Completion Date
November 1, 2025
Biopsy Procedure
Undergo tumor biopsy
Computed Tomography
Undergo CT scan
Dabrafenib Mesylate
Given PO
Echocardiography Test
Undergo ECHO
Magnetic Resonance Imaging
Undergo MRI
Multigated Acquisition Scan
Undergo MUGA
Tazemetostat Hydrobromide
Given PO
Trametinib Dimethyl Sulfoxide
Given PO
RECRUITING
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
RECRUITING
Wake Forest University Health Sciences, Winston-Salem
RECRUITING
Emory University Hospital/Winship Cancer Institute, Atlanta
ACTIVE_NOT_RECRUITING
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
ACTIVE_NOT_RECRUITING
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
RECRUITING
University of Wisconsin Carbone Cancer Center - Eastpark Medical Center, Madison
RECRUITING
University of Wisconsin Carbone Cancer Center - University Hospital, Madison
RECRUITING
Northwestern University, Chicago
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
Siteman Cancer Center-South County, St Louis
RECRUITING
Siteman Cancer Center at Christian Hospital, St Louis
RECRUITING
Siteman Cancer Center at West County Hospital, Creve Coeur
RECRUITING
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
RECRUITING
Huntsman Cancer Institute/University of Utah, Salt Lake City
National Cancer Institute (NCI)
NIH